Banque Cantonale Vaudoise Horizon Therapeutics Public LTD CO Transaction History

Banque Cantonale Vaudoise

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$96.34 - $112.38 $3,853 - $4,495	-40 Reduced 10.9%	327 $34,000
Q1 2023 Apr 20, 2023	SELL	$107.32 - $113.5 $454,285 - $480,445	-4,233 Reduced 92.02%	367 $40,000
Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $57,723 - $84,593	-727 Reduced 13.65%	4,600 $367,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $59,136 - $71,946	-600 Reduced 10.12%	5,327 $573,000
Q1 2021 May 11, 2021	SELL	$71.83 - $95.48 $411,083 - $546,432	-5,723 Reduced 49.12%	5,927 $546,000

Q4 2020 Feb 05, 2021	BUY	$67.0 - $84.39 $473,958 - $596,974	7,074 Added 154.59%	11,650 $852,000
Q3 2020 Oct 30, 2020	BUY	$55.23 - $79.93 $109,024 - $157,781	1,974 Added 75.86%	4,576 $355,000
Q2 2020 Jul 22, 2020	SELL	$30.2 - $56.98 $31,045 - $58,575	-1,028 Reduced 28.32%	2,602 $145,000
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $66,378 - $102,916	-2,669 Reduced 42.37%	3,630 $108,000
Q4 2019 Feb 10, 2020	BUY	$25.43 - $36.67 $160,183 - $230,984	6,299 New	6,299 $228,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.